Given that SESN2 plays a pivotal role in the modulation of inflammasomes activation and tumor growth by gAcrp, elucidation of the molecular basis by which adiponectin induces SESN2 expression would provide a potential therapeutic target for the treatment of cancer. This evidence concerns the gene ADIPOQ and neoplasm.